AP-1 confers resistance to anti-cancer therapy by activating XIAP

The underlying cause of treatment failure in many cancer patients is intrinsic and acquired resistance to chemotherapy. Recently, histone deacetylase (HDAC) inhibitors have developed into a promising cancer treatment. However, resistance mechanism induced by HDAC inhibitors remains largely unknown....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuan, Wan, Guo-Hui, Wu, Ying-Min, Wang, Hong-Sheng, Wang, Hai-Fang, Zhang, Ge, Lu, Lin-Lin, Li, Zi-Qian, Chan, Ka-Ying, Zhou, Yan, Cai, Shao-Hui, Qi, Yi-Fei, Du, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865658/
https://www.ncbi.nlm.nih.gov/pubmed/29581832
http://dx.doi.org/10.18632/oncotarget.23897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865658/
https://www.ncbi.nlm.nih.gov/pubmed/29581832
http://dx.doi.org/10.18632/oncotarget.23897

Ejemplares similares